Post-approval studies (Phase 4)Study completedNCT03800979
What this trial is testing
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
Who this might be right for
Alopecia Areata
Institute of Dermatology, Thailand 19